Translucence and Zeiss Team Up to Expand Possibilities for 3D Tissue Imaging

Translucence Biosystems

March 24, 2021

We are excited to announce that Translucence Biosystems has entered into a collaborative and strategic relationship with Carl Zeiss AG to promote the use of the Mesoscale Imaging System^TMwith the new ZEISS Lightsheet 7 microscope, designed to advance the 3D histology revolution.

Learn more about the Zeiss Lightsheet microscopes here.

‍

Ask your question

Send us your questions and we will get back to you as soon as possible
info@translucencebio.com

Thank you! Your submission has been received!

Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

June 15, 2023

Highlights from the 9th Annual BRAIN Initiative Meeting

Translucence Biosystems recently participated in the 9th Annual BRAIN Initiative Meeting: Open Science, New Tools! The conference, held on June 12-13, 2023, aimed to foster a dynamic and collaborative research community through interactions among like-minded scientists who study the brain.

Angela Prvulovic

Learn More

May 20, 2023

Co-Founder and CEO, Damian Wheeler Presents at KSNeurodegen23 on Brain-Wide Cellular-Resolution Quantification of Microglia and Amyloid

Co-Founder and CEO, Damian Wheeler, presented a poster titled "Brain-Wide Cellular-Resolution Quantification of Microglia and Amyloid" at the Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development conference hosted by the by Keystone Symposia on Molecular & Cellular Biology.

Angela Prvulovic

Learn More

March 23, 2023

CEO, Damian Wheeler Ph.D., Presents at the BIO-SEE 2023 Webinar Series

At the BIO-SEE 2023 Webinar Series, Damian Wheeler Ph.D., CEO of Translucence Biosystems, presented the company's innovative approach to brain-wide single-cell imaging in a talk entitled "Brain-wide single-cell resolution imaging and machine learning-enabled quantification".

Translucence Biosystems

Learn More